Publications 2011 – 2015

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF.
Publication: Ophthalmology. 2015

Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a phase 2 Study of intravitreal aflibercept.
Gonzalez VH, Boyer DS, Schmidt-Erfurth U, Heier JS, Gordon C, Benz MS, Marcus DM, Sabates NR, Vitti R, Kazmi H, Berliner AJ, Soo Y, Zhu X, Moini H, Zeitz O, Sandbrink R, Do DV.
Publication:Retina. 2015

Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography.
Waldstein SM, Faatz H, Szimacsek M, Glodan AM, Podkowinski D, Montuoro A, Simader C, Gerendas BS, Schmidt-Erfurth U.
Publication:Eye (Lond.) 2015

Pigment Epithelial Detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C.
Publication:Ophthalmology. 2015

Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments.
Waldstein SM, Gerendas BS, Montuoro A, Simader C, Schmidt-Erfurth U.
Publication: BR J Ophthalmol. 2015

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.
Ogura Y, Terasaki H, Gomi F, Yuzawa M, Iida T, Honda M, Nishijo K, Sowade O, Komori T, Schmidt-Erfurth U, Simader C, Chong V; for the VIEW 2 Investigators
Publication: Br J Ophthalmol. 2015

Intravitreal Aflibercept for Diabetic Macular Edema.
Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simder C, Soo Y, Schmelter T, Yancopoulos GD, sTahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM.
Publication: Ophthalmology. 2014

Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy.
Ritter M, Simader C, Bolz M, Deak GG, Mayr-Sponer U, Sayegh R, Kundi M, Schmidt-Erfurth U
Publication: Br J Ophthalmol. 2014

Three-Dimensional Automated Choroidal Volume Assessment on Standard Spectral-Domain Optical Coherence Tomography and Correlation With the Level of Diabetic Mauclar Edema.
Gerendas BS, Waldstein SM, Simader C, Deak G, Hajnajeeb B, Zhang L, Bogunovic H, Abramoff Md, Kundi M, Sonka M, Schmidt-Erfurth U
Publication: Am J Ophthalmol. 2014

A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy.
Simader C, Sayegh RG, Montuoro A, Azhary M, Koth AL, Barasits M, Sucu S, Prünte C, Kreil DP, Schmidt-Erfurth U.
Publication: Am J Ophthalmol. 2014

Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration.
Waldstein SM, Ritter M, Simader C, Mayr-Sponer U, Kundi M, Schmidt-Erfurth U.
Publication: Am J Ophthalmol. 2014

A systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic athrophy.
Sayegh CG, Kiss CG, Simader C, Kroisamer J, Montuoro, Mittermüller TJ, Azhary M, Bolz M, Kreil DP, Schmidt-Erfurth U.
Publication: Br. J. Ophthalmol. 2014

Morphologic Parameters Relevant for Visual Outcome During Anti Angiogenic Therapy of Neovascular Age-Related Macular Degeneration.
Simader C, Ritter M, Bolz M, Deák GG, Mayr-Sponer U. Golbaz I, Kundi M, Schmidt-Erfurth U.
Publication: Ophthalmology. 2014

Three-Year Outcomes of Individualizaed Ranibizumab Treatment in Patients with Diabetic Macular Edema: The RESTORE Extension Study.
Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P; the RESTORE extension study group.
Publication: Ophthalmology. 2014

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 Galileo Study.
Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, Lorenz K, Honda M, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group
Publication: Ophthalmology. 2014

Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results of the VIEW Studies.
Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS
Publication: Ophthalmology. 2014

Influence of the Vitreomacular Interface on Outcomes of Ranibizumab Therapy in Neovascular Age-related Macular Degeneration.
Mayr-Sponer U, Waldstein SM, Kundi M, Ritter M, Golbaz I, Heiling U, Papp A, Simader C, Schmidt-Erfurth U
Publication: Ophthalmology. 2013

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups.
Publication: Ophthalmology. 2012

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.
Larsen M, Schmidt-Erfurth U, Lanzetta P, Wolf S, Simader C, Tokaji E, Pilz S, Weisberger A; MONT BLANC Study Group.
Publication: Ophthalmology. 2012

Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study.
Waldstein SM, Sponer U, Simader C, Sacu S, Schmidt-Erfurth U.
Publication: Retina. 2012

A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. 
Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U.
Publication: Ophthalmology. 2011

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A; RESTORE study group.
Publication: Ophthalmology. 2011

Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.
Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A; EXCITE Study Group.
Publication:Ophthalmology. 2011

Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres.
Ritter M, Elledge J, Simader C, Deak GG, Benesch T, Blodi BA, Schmidt-Erfurth UM. 
Publication: Br J Ophthalmol. 2011